Erasca Foundation proposes $151K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. (ERAS) is identified as issuer in a notice listing Erasca Foundation’s proposed sale of 8,333 common shares, with an approximate sale date of April 15, 2026 and an aggregate market value of $150,843.19. Merrill Lynch is named as broker, and the sale is associated with a Rule 10b5-1 plan adopted January 10, 2024. Erasca Foundation’s relationship to the issuer is listed as “Foundation.”
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.